Search research articles
Contact Us
Filters
Showing results (261-270 of 287) with videos related to
Page
of 29
Sort By:
Journal of Fish Biology
|
April 11, 2016
Using genetic inference to re-evaluate the minimum longevity of the lemon shark Negaprion brevirostris
J L Brooks, T L Guttridge, B R Franks, et al.
Molecular Biotherapy
|
September 1, 1990
Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience
H Kirchner, A Körfer, P A Palmer, et al.
Bone Marrow Transplantation
|
September 1, 1989
Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantation
M C Favrot, D Floret, S Negrier, et al.
Journal of Theoretical Biology
|
November 9, 2010
Comment on P. Nouvellet, J.P. Bacon, D. Waxman, "Testing the level of ant activity associated with quorum sensing: An empirical approach leading to the establishment and test of a null-model"
T O Richardson, E J H Robinson, K Christensen, et al.
European Journal of Pharmacology
|
September 25, 1999
Expression and characterisation of human and rat CRF2alpha receptors
N Suman-Chauhan, P Carnell, R Franks, et al.
Cancer Immunology, Immunotherapy : CII
|
July 1, 1994
Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose
P A Palmer, J G Scharenberg, B M von Blomberg, et al.
Molecular and Cellular Biology
|
October 12, 2000
Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis
F M Rausa, Y Tan, H Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Combination IL-2 and cisplatinum: a promising treatment for bronchioloalveolar carcinoma?
V Trillet-Lenoir, D Arpin, A Mercatello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2
J G Scharenberg, A G Stam, B M von Blomberg, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
February 1, 1992
Phase I trial of recombinant interleukin-2 followed by recombinant tumor necrosis factor in patients with metastatic cancer
M S Negrier, C N Pourreau, P A Palmer, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 287) with videos related to
Sort By:
Page
of 29
Journal of Fish Biology
|
April 11, 2016
Using genetic inference to re-evaluate the minimum longevity of the lemon shark Negaprion brevirostris
J L Brooks, T L Guttridge, B R Franks, et al.
Molecular Biotherapy
|
September 1, 1990
Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience
H Kirchner, A Körfer, P A Palmer, et al.
Bone Marrow Transplantation
|
September 1, 1989
Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantation
M C Favrot, D Floret, S Negrier, et al.
Journal of Theoretical Biology
|
November 9, 2010
Comment on P. Nouvellet, J.P. Bacon, D. Waxman, "Testing the level of ant activity associated with quorum sensing: An empirical approach leading to the establishment and test of a null-model"
T O Richardson, E J H Robinson, K Christensen, et al.
European Journal of Pharmacology
|
September 25, 1999
Expression and characterisation of human and rat CRF2alpha receptors
N Suman-Chauhan, P Carnell, R Franks, et al.
Cancer Immunology, Immunotherapy : CII
|
July 1, 1994
Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose
P A Palmer, J G Scharenberg, B M von Blomberg, et al.
Molecular and Cellular Biology
|
October 12, 2000
Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis
F M Rausa, Y Tan, H Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Combination IL-2 and cisplatinum: a promising treatment for bronchioloalveolar carcinoma?
V Trillet-Lenoir, D Arpin, A Mercatello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2
J G Scharenberg, A G Stam, B M von Blomberg, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
February 1, 1992
Phase I trial of recombinant interleukin-2 followed by recombinant tumor necrosis factor in patients with metastatic cancer
M S Negrier, C N Pourreau, P A Palmer, et al.
Page
of 29